Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.

@article{Bie2007ClinicalPR,
  title={Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.},
  author={Rob M A de Bie and Janis Miyasaki and Anthony E Lang and Susan H. Fox},
  journal={The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques},
  year={2007},
  volume={34 4},
  pages={
          438-42
        }
}
BACKGROUND Current Health Canada instructions for use of the dopamine agonists (DA), pramipexole and ropinirole, state that Parkinson's disease (PD) patients should be told not to drive. The objective was to assess neurologists' actual clinical practice concerning driving advice they give to PD patients starting a DA. METHODS An online survey was created consisting of 4 items regarding demographics, 5 regarding PD and driving, and 9 regarding DA use and driving. The survey was distributed to… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

Effects of parkinsonian medication on sleep

  • D Schafer, W. Greulich
  • J Neurol
  • 2000

Similar Papers

Loading similar papers…